Reappraisal of guidelines for management of neonates with suspected early-onset sepsis

Journal of Pediatrics

Volumn 166, Issue 4, 2015, Pages 1070-1074

  Benitz, William E ^a   Wynn, James L ^b   Polin, Richard A ^c  

^a STANFORD UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; CHORIOAMNIONITIS; EARLY ONSET NEONATAL SEPSIS; GROUP B STREPTOCOCCAL INFECTION; HUMAN; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; NOTE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; DISEASE MANAGEMENT; SEPSIS; STANDARDS; TIME;

DISEASE MANAGEMENT; HUMANS; INFANT, NEWBORN; PRACTICE GUIDELINES AS TOPIC; SEPSIS; TIME FACTORS;

EID: 84933280021     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.12.023     Document Type: Note

References (54)

1. Committee on Infectious Diseases, Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 1992;90:775-8.
2. Committee on Technical Bulletins. Group B streptococcal infections in pregnancy. ACOG Technical Bulletin Number 170. Int J Gynaecol Obstet 1993;42:55-9.
3. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR Recomm Rep 1996;45:1-24.
4. Committee on Obstetric Practice. Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion Number 173. Int J Gynaecol Obstet 1996;54:197-205.
5. Committee on Infectious Diseases, Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997;99:489-96.
6. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51:1-22.
7. Committee on Obstetric Practice. Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion Number 279. Obstet Gynecol 2002;100:1405-12.
8. Verani JR, McGee L, Schrag SJ. Prevention of Perinatal Group B Streptococcal Disease-Revised Guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1-36.
9. American Academy of Pediatrics. Statement of Endorsement-perinatal group B streptococcal disease. Pediatrics 2010;127:396.
10. Committee on Obstetric Practice. Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion Number 485. Obstet Gynecol 2011;117:1019-27.
11. Committee on Infectious Diseases, Committee on Fetus and Newborn. Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics 2011;128:611-6.
12. Polin RA, Papile L, Baley J, Benitz W, Carlo W, Cummings J, et al. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012;129:1006-15.
13. Infectious Diseases and Immunization Committee. The prevention of early-onset group B streptococcal infections in the newborn. Can J Infect Dis 1994;5:251-6.
14. Money D, Allen VM, Society of Obstetricians and Gynaecologists of Canada. The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can 2013;35:939-51.
15. Demianczuk NN, Halperin SA, McMillan DD. Prevention of perinatal group B streptococcal infection: management strategies. Can J Infect Dis 1997;8:68-70.
16. National Collaborating Centre for Women's and Children's Health. Antibiotics for early-onset neonatal infection: Antibiotics for the prevention and treatment of early-onset neonatal infection (CG149). London: National Institute for Health and Clinical Excellence; 2012.
17. Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, et al. Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis 2012;31:2097-104.
18. Brady MT, Polin RA. Prevention and management of infants with suspected or proven neonatal sepsis. Pediatrics 2013;132:166-8.
19. Mukhopadhyay S, Dukhovny D, Mao W, Eichenwald EC, Puopolo KM. 2010 perinatal GBS prevention guideline and resource utilization. Pediatrics 2014;133:196-203.
20. Malloy MH. Chorioamnionitis: epidemiology of newborn management and outcome United States 2008. J Perinatol 2014;34:611-5.
21. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
22. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report: Group B streptococcus, 2012. Centers for Disease Control and Prevention; 2013, http://www.cdc.gov/abcs/ reports-findings/survreports/gbs12.pdf. Accessed December 16, 2014.
23. Cordero L, Rau R, Taylor D, Ayers LW. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit. Am J Infect Control 2004;32:189-95.
24. Sanghvi KP, Tudehope DI. Neonatal bacterial sepsis in a neonatal intensive care unit: A 5 year analysis. J Paediatr Child Health 1996;32:333-8.
25. Isaacs D, Barfield CP, Grimwood K, McPhee AJ, Minutillo C, Tudehope DI, et al. Systemic bacterial and fungal infections in infants in Australian neonatal units. Med J Aust 1995;162:198-201.
26. Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early onset neonatal sepsis: The burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011;127:817-26.
27. Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011;30:937-41.
28. Escobar GJ, Puopolo KM, Wi S, Turk BJ, Kuzniewicz MW, Walsh EM, et al. Stratification of risk of early-onset sepsis in newborns >/= 34 weeks' gestation. Pediatrics 2014;133:30-6.
29. Jackson GL, Rawiki P, Sendelbach D, Manning MD, Engle WD. Hospital course and short-term outcomes of term and late preterm neonates following exposure to prolonged rupture of membranes and/or chorioamnionitis. Pediatr Infect Dis J 2012;31:89-90.
30. Kiser C, Nawab U, McKenna K, Aghai ZH. Role of guidelines on length of therapy in chorioamnionitis and neonatal sepsis. Pediatrics 2014;133:992-8.
31. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000;106:244-50.
32. Ottolini MC, Lundgren K, Mirkinson LJ, Cason S, Ottolini MG. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003;22:430-4.
33. Hashavya S, Benenson S, Ergaz-Shaltiel Z, Bar-Oz B, Averbuch D, Eventov-Friedman S. The use of blood counts and blood cultures to screen neonates born to partially treated group B Streptococcus-carrier mothers for early-onset sepsis: is it justified? Pediatr Infect Dis J 2011; 30:840-3.
34. Flidel-Rimon O, Galstyan S, Juster-Reicher A, Rozin I, Shinwell ES. Limitations of the risk factor based approach in early neonatal sepsis evaluations. Acta Paediatr 2012;101:e540-4.
35. Cantoni L, Ronfani L, Da Riol R, Demarini S, Perinatal Study Group of the Region Friuli-Venezia Giulia. Physical examination instead of laboratory tests for most infants born to mothers colonized with group B Streptococcus: support for the Centers for Disease Control and Prevention's 2010 recommendations. J Pediatr 2013;163:568-73.
36. Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998;102:E41.
37. Mikhael M, Brown LS, Rosenfeld CR. Serial neutrophil values facilitate predicting the absence of neonatal early-onset sepsis. J Pediatr 2014; 164:522-8.
38. Murphy K, Weiner J. Use of leukocyte counts in evaluation of earlyonset neonatal sepsis. Pediatr Infect Dis J 2012;31:16-9.
39. Pourcyrous M, Bada HS, Korones SB, Baselski V, Wong SP. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993;92:431-5.
40. Gibbs RS, Castillo MS, Rodgers PJ. Management of acute chorioamnionitis. Am J Obstet Gynecol 1980;136:709-13.
41. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999;103:e77.
42. Velaphi S, Siegel JD, Wendel GD Jr, Cushion N, Eid WM, Sanchez PJ. Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics 2003;111:541-7.
43. Yancey MK, Duff P, Kubilis P, Clark P, Frentzen BH. Risk factors for neonatal sepsis. Obstet Gynecol 1996;87:188-94.
44. Jackson GL, Engle WD, Sendelbach DM, Vedro DA, Josey S, Vinson J, et al. Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis? Pediatrics 2004;113:1173-80.
45. Soraisham AS, Singhal N, McMillan DD, Sauve RS, Lee SK, Canadian Neonatal N. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am J Obstet Gynecol 2009;200:372.e1-6.
46. Pappas A, Kendrick DE, Shankaran S, Stoll BJ, Bell EF, Laptook AR, et al. Chorioamnionitis and early childhood outcomes among extremely lowgestational-age neonates. JAMA Pediatr 2014;168:137-47.
47. Gagliardi L, Rusconi F, Bellu R, Zanini R, Italian Neonatal Network. Association of maternal hypertension and chorioamnionitis with preterm outcomes. Pediatrics 2014;134:e154-61.
48. Garcia-Munoz Rodrigo F, Galan Henriquez G, Figueras Aloy J, Garcia-Alix Perez A. Outcomes of very-low-birth-weight infants exposed to maternal clinical chorioamnionitis: A multicentre study. Neonatology 2014;106:229-34.
49. Garcia-Munoz Rodrigo F, Galan Henriquez GM, Ospina CG. Morbidity and mortality among very-low-birth-weight infants born to mothers with clinical chorioamnionitis. Pediatr Neonatol 2014;55:381-6.
50. Buckler B, Bell J, Sams R, Cagle W, Bell SA, Allen C, et al. Unnecessary workup of asymptomatic neonates in the era of group B streptococcus prophylaxis. Infect Dis Obstet Gynecol 2010;2010:1-3.
51. Cuna A, Hakima L, Tseng YA, Fornier B, Islam S, Quintos-Alagheband ML, et al. Clinical dilemma of positive histologic chorioamnionitis in term newborn. Front Pediatr 2014;2:1-5.
52. Puopolo KM, Draper D, Wi S, Newman TB, Zupancic J, Lieberman E, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 2011;128:e1155-63.
53. Escobar GJ, Puopolo KM, Wi S, Turk BJ, Kuzniewicz MW, Walsh EM, et al. Erratum to: Stratification of risk of early-onset sepsis in newborns >/= 34 weeks' gestation. Pediatrics 2014;134:193.
54. Berardi A, Fornaciari S, Rossi C, Patianna V, Bacchi Reggiani ML, Ferrari F, et al. Safety of physical examination alone for managing well-appearing neonates >/=35 weeks' gestation at risk for early-onset sepsis. J Matern Fetal Neonatal Med 2014. In press.